Gilead Sciences Announces Third Quarter 2016 Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Jefferies Remains Sidelined on Gilead Sciences (GILD) Following 2Q - PT to $93
July 26, 2016 9:15 AM EDTJefferies maintained a Hold rating on Gilead Sciences (NASDAQ: GILD), and cut the price target to $93.00 (from $97.00) following the company's 2Q earnings report. GILD's strong bottom-line results were driven by HIVB strength, as well as buybacks. HIV sales remain strong, with particular... More
Gilead Sciences (GILD) Declares $0.47 Quarterly Dividend; 2.1% Yield
July 25, 2016 4:10 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.47 per share, or $1.88 annualized.
The dividend will be payable on September 29, 2016, to stockholders of record on September 16, 2016, with an ex-dividend date of September 14, 2016.
The annual yield on the dividend is 2.1... More
Gilead Sciences (GILD) Declares $0.47 Quarterly Dividend; 2.1% Yield
July 25, 2016 4:10 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.47 per share, or $1.88 annualized.
The dividend will be payable on September 29, 2016, to stockholders of record on September 16, 2016, with an ex-dividend date of September 14, 2016.
The annual yield on the dividend is 2.1... More
